The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397)
Open Access
- 28 November 2006
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 99 (2), 301-310
- https://doi.org/10.1111/j.1464-410x.2006.06560.x
Abstract
OBJECTIVE To explore patients’ quality of life (QoL) during neoadjuvant hormone therapy (HT) using data from the Medical Research Council RT01 trial of standard‐ (64 Gy/32‐fraction) and high‐ (74 Gy/37‐fraction) dose radiotherapy (RT, both given conformally). PATIENTS AND METHODS Of the 843 patients randomized to the RT01 trial, 316 completed the Functional Assessment Of Cancer Therapy core questionnaire with its additional prostate subscale, and the Short Form‐36 Health Survey questionnaire with the University of California‐Los Angeles Prostate Cancer Index before HT and again before starting RT. Three predefined QoL hypotheses were generated to focus the analyses. RESULTS For the three primary QoL analyses there was evidence that sexual functioning deteriorated, urinary function did not change, and there was a slight decline in physical well‐being after ≥ 3 months of HT. Sensitivity analyses confirmed these findings. Exploratory analyses also suggested that role functioning deteriorated, sleep was more disturbed, and there was an increase in fatigue. However, overall QoL was not reported to be affected and patients indicated an improvement in attitude and satisfaction with treatment. CONCLUSIONS In this group of men, many of whom reported reduced sexual functioning before treatment, the additional decline during HT seemed to be generally accepted as the price to pay for an appropriate cancer treatment. Nevertheless, these changes need to be discussed with patients before HT is commenced.This publication has 52 references indexed in Scilit:
- Preferences of hxealthy men for two different endocrine treatment options offered for locally advanced prostate cancerCurrent Medical Research and Opinion, 2005
- Hormone Therapy for Locally Advanced Prostate CancerJournal of Urology, 2002
- The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinomaCancer, 2002
- Feasibility Study: Watchful Waiting For Localized Low To Intermediate Grade Prostate Carcinoma With Selective Delayed Intervention Based On Prostate Specific Antigen, Histological And/Or Clinical ProgressionJournal of Urology, 2002
- QUALITY OF LIFE OF ASYMPTOMATIC MEN WITH NONMETASTATIC PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPYJournal of Urology, 2000
- The UCLA Prostate Cancer IndexMedical Care, 1998
- DIFFERENCES IN UROLOGIST AND PATIENT ASSESSMENTS OF HEALTH RELATED QUALITY OF LIFE IN MEN WITH PROSTATE CANCERJournal of Urology, 1998
- The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853European Journal of Cancer, 1996
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Psychosocial Status of Cancer Patients and Next of KinJournal of Psychosocial Oncology, 1985